[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.159.197.114. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
December 28, 2005

Regulation of Medical Marijuana—Reply

Author Affiliations
 

Letters Section Editor: Robert M. Golub, MD, Senior Editor.

JAMA. 2005;294(24):3091-3092. doi:10.1001/jama.294.24.3091-b

In Reply: Dr Das suggests a reasoned way to think about the use of marijuana for medical purposes. My Commentary also offers a regulatory approach based on scientific evidence. It proposes rigorous research of marijuana's safety and effectiveness, using a dose of fixed purity and strength. Regulatory review and clinical judgment would be based on the research data. For pharmaceuticals (such as morphine) that are proven effective but that still can produce undesirable risks and social consequences, there should be additional regulatory control and oversight. That is the proven standard for approval and use of pharmaceuticals, and marijuana should not be an exception.

First Page Preview View Large
First page PDF preview
First page PDF preview
×